Neurological complications of breast cancer: A prospective cohort study

Breast

Volumn 24, Issue 5, 2015, Pages 582-587

  Pereira, Susana ^a,b   Fontes, Filipa ^b,c   Sonin, Teresa ^a   Dias, Teresa ^a   Fragoso, Maria ^a   Castro Lopes, José Manuel ^c,d   Lunet, Nuno ^b,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Breast Neoplasm; Nervous system diseases; Neuropathic pain; Polyneuropathies

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; MENTAL DETERIORATION; MULTIPLE CYCLE TREATMENT; NEUROLOGICAL COMPLICATION; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TREATMENT PLANNING; WOMEN'S HEALTH; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; BREAST NEOPLASMS; CHEMICALLY INDUCED; COGNITION DISORDERS; COMPLICATION; INCIDENCE; LYMPH NODE DISSECTION; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEURALGIA; PORTUGAL; PROSPECTIVE STUDY; SENSATION DISORDERS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEURALGIA; PORTUGAL; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SENSATION DISORDERS;

EID: 84952638363     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2015.05.006     Document Type: Article

References (29)

1. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 2013, International Agency for Research on Cancer, Lyon, France, [accessed on 01.01.15]. http://globocan.iarc.fr/.
2. De Angelis R., Sant M., Coleman M.P., Francisci S., Baili P., Pierannunzio D., et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014, 15(1):23-34.
3. Howlader N., Noone A., Krapcho M., Garshell J., Neyman N., Altekruse S., et al. SEER Cancer Statistics Review, 1975-2011 2013, National Cancer Institute, Bethesda, MD, SEER. Available from:, [accessed 01.11.14]. http://seer.cancer.gov/csr/1975_2011/.
4. Verdecchia A., Guzzinati S., Francisci S., De Angelis R., Bray F., Allemani C., et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009, 45(6):1042-1066.
5. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. Lancet 2012, 380(9855):1778-1786.
6. Giglio P., Gilbert M.R. Neurologic complications of cancer and its treatment. Curr Oncol Rep 2010, 12(1):50-59.
7. Khasraw M., Posner J.B. Neurological complications of systemic cancer. Lancet Neurol 2010, 9(12):1214-1227.
8. Weil R.J., Palmieri D.C., Bronder J.L., Stark A.M., Steeg P.S. Breast cancer metastasis to the central nervous system. Am J Pathol 2005, 167(4):913-920.
9. Seretny M., Currie G.L., Sena E.S., Ramnarine S., Grant R., MacLeod M.R., et al. Incidence, prevalence and predictors of chemotherapy induced peripheral neuropathy: a systematic review and meta-analysis. Pain 2014, 155(12):2461-2470.
10. Jung B.F., Ahrendt G.M., Oaklander A.L., Dworkin R.H. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 2003, 104(1-2):1-13.
11. Gilbert M.R., Grossman S.A. Incidence and nature of neurologic problems in patients with solid tumors. Am J Med 1986, 81(6):951-954.
12. Hildebrand J. Lesions of the nervous system in cancer patients 1978, Raven Press, New York, 150 p.
13. Clouston P.D., DeAngelis L.M., Posner J.B. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 1992, 31(3):268-273.
14. Pereira S., Fontes F., Sonin T., Dias T., Fragoso M., Castro-Lopes J., et al. Neurological complications of breast cancer: study protocol of a prospective cohort study. BMJ Open 2014, 4(10):e006301.
15. Freitas S., Simoes M.R., Alves L., Santana I. Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population. J Clin Exp Neuropsychol 2011, 33(9):989-996.
16. Freitas S., Simões M.R., Martins C., Vilar M., Santana I. [Estudos de adaptação do Montreal Cognitive Assessment (MoCA) para a população portuguesa]. Avaliação Psicológica 2010, 9:345-357.
17. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53(4):695-699.
18. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70(18):1630-1635.
19. Cruccu G., Sommer C., Anand P., Attal N., Baron R., Garcia-Larrea L., et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol Official J Eur Fed Neurol Soc 2010, 17(8):1010-1018.
20. CTCAE Cancer therapy evaluation Program, common terminology criteria for adverse events, version 4.0. DCTD, NCI, NIH, DHHS 2010, [accessed 01.01.12]. http://ctep.cancer.gov/.
21. Azevedo L.F., Pereira A.C., Dias C., Agualusa L., Lemos L., Romão J., et al. Dor 2007, 15:6-56.
22. Cleeland C.S., Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994, 23(2):129-138.
23. Jung B.F., Herrmann D., Griggs J., Oaklander A.L., Dworkin R.H. Neuropathic pain associated with non-surgical treatment of breast cancer. Pain 2005, 118(1-2):10-14.
24. Cavaletti G., Zanna C. Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. Eur J Cancer 2002, 38(14):1832-1837.
25. Windebank A.J., Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008, 13(1):27-46.
26. Gacio M., Agrelo A., Pereira S., Castro C., Santos J. Braz J Anesthesiol 2015, (in press).
27. Stewart A., Bielajew C., Collins B., Parkinson M., Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006, 20(1):76-89.
28. Falleti M.G., Sanfilippo A., Maruff P., Weih L., Phillips K.A. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 2005, 59(1):60-70.
29. Tannock I.F., Ahles T.A., Ganz P.A., Van Dam F.S. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol Off J Am Soc Clin Oncol 2004, 22(11):2233-2239.